Fil LTD Trans Medics Group, Inc. Transaction History

Fil LTD

$106 Billion
Q2 2025

A detailed history of Fil LTD transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Fil LTD holds 1,055,553 shares of TMDX stock, worth $138 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,055,553

Previous 1,225,973 13.9%

Holding current value

$138 Million

Previous $82.5 Million 71.49%

% of portfolio

0.13%

Previous 0.09%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$67.67 - $143.04 $11.5 Million - $24.4 Million	-170,420 Reduced 13.9%	1,055,553 $141 Million
Q1 2025 May 12, 2025	BUY	$56.73 - $79.42 $12.8 Million - $17.9 Million	225,615 Added 22.55%	1,225,973 $82.5 Million
Q4 2024 Feb 13, 2025	BUY	$59.28 - $144.9 $13 Million - $31.7 Million	218,961 Added 28.02%	1,000,358 $62.4 Million
Q3 2024 Nov 13, 2024	BUY	$135.68 - $176.11 $54.9 Million - $71.2 Million	404,560 Added 107.36%	781,397 $123 Million
Q2 2024 Aug 13, 2024	BUY	$72.62 - $150.62 $15.7 Million - $32.5 Million	215,951 Added 134.23%	376,837 $56.8 Million
Q1 2024 May 13, 2024	BUY	$70.86 - $89.93 $11 Million - $14 Million	155,886 Added 3117.72%	160,886 $11.9 Million
Q4 2023 Feb 13, 2024	BUY	$36.74 - $81.08 $183,700 - $405,400	5,000 New	5,000 $394,000
Q3 2022 Nov 10, 2022	SELL	$31.56 - $55.75 $3.88 Million - $6.85 Million	-122,859 Reduced 44.28%	154,608 $6.45 Million
Q2 2022 Aug 12, 2022	SELL	$20.56 - $32.15 $35,507 - $55,523	-1,727 Reduced 0.62%	277,467 $8.73 Million
Q1 2022 May 13, 2022	BUY	$12.58 - $26.94 $3.51 Million - $7.52 Million	279,194 New	279,194 $7.52 Million

Others Institutions Holding TMDX

# of Institutions

414

Shares Held

29.7M

Call Options Held

1.19M

Put Options Held

777K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $4.17B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account